High variability in serum estradiol measurements in men and women

Steroids

Volumn 82, Issue , 2014, Pages 7-13

  Vesper, Hubert W ^a   Botelho, Julianne C ^a   Vidal, Meghan L ^a   Rahmani, Yasamin ^a   Thienpont, Linda M ^b   Caudill, Samuel P ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Analytical variability; Assay comparison; Estradiol

Indexed keywords

ESTRADIOL;

ACCURACY; ADULT; ARTICLE; CALIBRATION; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PATIENT CARE; POSTMENOPAUSE; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; AGED; BLOOD; MIDDLE AGED; SEXUAL DEVELOPMENT; STANDARD; STATISTICAL BIAS; YOUNG ADULT;

ADULT; AGED; BIAS (EPIDEMIOLOGY); CALIBRATION; ESTRADIOL; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE STANDARDS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84893088517     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.12.005     Document Type: Article

References (31)

1. T. Key, P. Appleby, I. Barnes, and G. Reeves Endogenous hormones and breast cancer collaborative group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 2002 606 616 (Pubitemid 34498648)
2. R. Kaaks, S. Rinaldi, T.J. Key, F. Berrino, P.H. Peeters, and C. Biessy et al. Postemenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Enocr Rlat Cancer 12 2005 1071 1082 (Pubitemid 41815798)
3. S.A. Missmer, A.H. Eliassen, R.L. Barbieri, and S.E. Hankinson Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women J Natl Cancer Inst 96 2004 1856 1865 (Pubitemid 40081323)
4. T.J. Key, P.N. Appleby, G.K. Reeves, A.W. Roddam, K.J. Helzlsouer, and A.J. Alberg et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies Br J Cancer 105 2011 709 722
5. X. Zhang, S.S. Tworoger, A.H. Eliassen, and S.E. Hankinson Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up Breast Cancer Res Treat 137 2013 883 892
6. J.S. Lee, K. Yaffe, L.Y. Lui, J. Cauley, B. Taylor, and W. Browner et al. Prospective study of endogenous circulating estradiol and risk of stroke in older women Arch Neurol 67 2010 195 201
7. Y. Chen, A. Zeleniuch-Jacquotte, A.A. Arslan, O. Wojcik, P. Toniolo, and R.E. Shore et al. Endogenous hormones and coronary heart disease in postmenopausal women Atherosclerosis 216 2011 414 419
8. G.A. Laughlin, D. Kritz-Silverstein, and E. Barrett-Connor Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo study Clin Endocrinol (Oxf) 72 2010 99 106
9. A.W. Roddam, P. Appleby, R. Neale, M. Dowsett, E. Folkerd, and S. Tipper et al. Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study J Bone Miner Metab 27 2009 485 493
10. ClinicalTrials.gov search for estradiol estradiol | Recruiting | Exclude Unknown. Available at: < http://clinicaltrials.gov >; [accessed 24.06.2013].
11. http://www.cap.org/apps/cap.portal?-nfpb=true&cntvwrPtlt- actionOverride=%2Fportlets%2FcontentViewer%2Fshow&-windowLabel= cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=cap- today%2F0611%2F0611-CAPTODAY-ImmunoanalyzersGuide.html&-state= maximized&-pageLabel=cntvwr; [accessed 26.06.2013].
12. F.Z. Stanczyk, and N.J. Clarke Advantages and challenges of mass spectrometry assays for steroid hormones J Steroid Biochem Mol Biol 121 2010 491 495
13. N.B. Watts, R.A. Adler, J.P. Bilezikian, M.T. Drake, R. Eastell, and E.S. Orwoll et al. Osteoporosis in men: an endocrine society clinical practice guideline J Clin Endocrinol Metab 97 2012 1802 1822
14. W. Rosner, S.E. Hankinson, P.M. Sluss, H.W. Vesper, and M.E. Wierman Challenges to the measurement of estradiol: an endocrine society position statement J Clin Endocrinol Metab 98 2013 1376 1387
15. Clinical Laboratory Standards Institute. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures. (CLSI document C-37A). Wayne, PA: Clinical Laboratory Standards Institute; 1999.
16. L.M. Thienpont, G.V. Patrick, K.A. Van Brussel, and A.P. De Leenheer Estradiol-17β quantified in serum by isotope dilution-gas chromatography-mass spectrometry: reversed-phase C18 high-performance liquid chromatography compared with immune-affinity chromatography for sample pretreatment Clin Chem 34 1988 2066 2069
17. J.C. Botelho, C. Shacklady, and H.W. Vesper Development of a candidate reference measurement procedure for the determination of estradiol in human serum Clin Chem 57 Suppl. 2011 A1
18. Clinical Laboratory Standards Institute. Method comparison and bias estimation using patient samples. (CLSI document EP9). Wayne, PA: Clinical Laboratory Standards Institute. 2002.
19. W. Coucke, N. Devleeschouwer, J.C. Libeer, J. Schiettecatte, M. Martin, and J. Smitz Accuracy and reproducibility of automated estradiol-17β and progesterone assays using native serum samples: results obtained in the Belgian external assessment scheme Hum Reprod 22 2007 3204 3209 (Pubitemid 351696783)
20. D.T. Yang, W.E. Owen, C.S. Ramsay, H. Xie, and W.L. Roberts Performance characteristics of eight estradiol immunoassays Am J Clin Pathol 122 2004 332 337 (Pubitemid 39145537)
21. J. Reinsberg, O. Bätz, T. Bertsch, N. Bewarder, W. Deschner, and V. Drescher et al. Precision and long-term stability of different estradiol immunoassays assessed in a multi-center quality control study Clin Lab 55 2009 201 206
22. Middle JG. External quality assessment of steroid hormone assays in the United Kingdom. Ann 1st Super Sanita. 1991;27:459-466.
23. S. Vujovic, M. Brincat, T. Erel, M. Gambacciani, I. Lambrinoudaki, and M.H. Moen et al. EMAS position statement: managing women with premature ovarian failure Maturitas 67 2010 91 93
24. B.B. Yeap, H. Alfonso, S.A. Chubb, D.J. Handelsman, G.J. Hankey, and P.E. Norman et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men J Clin Endocrinol Metab 97 2012 4030 4039
25. T. Nagao, M. Kira, M. Takahashi, J. Honda, T. Hirose, and A. Tangoku et al. Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration World J Surg Oncol 7 2009 88
26. J. Jaque, H. Macdonald, D. Brueggmann, S.K. Patel, C. Azen, and N. Clarke et al. Deficiencies in immunoassay methods used to monitor serum estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients SpringerPlus 2 2013 5
27. CDC. < http://www.cdc.gov/labstandards/hs.html >; [accessed 26.06.2013].
28. C.G. Fraser, A. Kallner, D. Kenny, and P.H. Petersen Introduction: strategies to set global quality specifications in laboratory medicine Scand J Clin Lab Invest 59 1999 477 478 (Pubitemid 30056735)
29. C. Ricós, V. Alvarez, F. Cava, J.V. García-Lario, A. Hernández, and C.V. Jiménez et al. Current databases on biological variation: pros, cons and progress Scand J Clin Lab Invest 59 1999 491 500 (Pubitemid 30056739)
30. L. Thienpont Meeting report: first and second estradiol international workshop Clin Chem 42 1996 112 114
31. T.J. Key Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women Steroids 76 2011 812 815